Triple-negative breast cancer (TNBC) is immunohistochemically defined by the lack of expression of estrogen receptor (ER) and progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.